Tedesco Anthony, Ally Ahmmed
Department of Pharmaceutical Sciences, Massachusetts College of Pharmacy and Health Sciences, 179 Longwood Avenue, Boston, MA 02115, USA.
Neurosci Res. 2009 Aug;64(4):372-9. doi: 10.1016/j.neures.2009.04.008. Epub 2009 Apr 18.
Angiotensin II receptors (Ang II), classified into AT1 and AT2 subtypes, are located in different regions of the central nervous system, including the cardiovascular control centers in the medulla oblongata. We previously reported the role of Ang II AT1 receptors within the medulla on cardiovascular responses and glutamate/GABA neurotransmission during the exercise pressor reflex [Patel, D., Böhlke, M., Phattanarudee, S., Kabadi, S., Maher, T.J., Ally, A., 2008. Cardiovascular responses and neurotransmitter changes during blockade of angiotensin II receptors within the ventrolateral medulla. Neurosci. Res. 60 (3), 340-348]. In this study, we investigated the role of the AT2 receptor subtype within the ventrolateral medullary region (VLM) in modulating increases in mean arterial pressure (MAP) and heart rate (HR) in response to static skeletal muscle contraction.
Using microdialysis methods in anesthetized rats, we administered AR-AT2 antagonists into the rostral (RVLM) and caudal (CVLM) VLM and determined its effects on cardiovascular responses and glutamate/GABA neurotransmission following muscle contraction. Bilateral microdialysis of a selective AT2 antagonist, PD 123319 (10 microM), for 30 min into the RVLM augmented MAP and HR responses during a static muscle contraction. Simultaneously, the drug increased glutamate and decreased GABA levels within the RVLM. After 60 min of discontinuation of the drug, only MAP and HR values but not the neurotransmitter levels in response to a muscle contraction returned to baseline. In contrast, bilateral microdialysis of the drug into the CVLM attenuated cardiovascular responses during a static muscle contraction, decreased glutamate and increased GABA. However, only the cardiovascular responses recovered after 60 min of discontinuation of the drug. These results demonstrate that AT2 within both RVLM and CVLM plays important differential roles in modulating neurotransmission and cardiovascular function during the exercise pressor reflex.
血管紧张素II受体(Ang II)分为AT1和AT2亚型,位于中枢神经系统的不同区域,包括延髓中的心血管控制中心。我们之前报道了延髓内Ang II AT1受体在运动加压反射过程中对心血管反应和谷氨酸/γ-氨基丁酸神经传递的作用[帕特尔,D.,博尔克,M.,帕塔纳鲁迪,S.,卡巴迪,S.,马赫,T.J.,艾利,A.,2008年。延髓腹外侧区血管紧张素II受体阻断期间的心血管反应和神经递质变化。神经科学研究。60(3),340 - 348]。在本研究中,我们研究了腹外侧髓质区(VLM)内的AT2受体亚型在调节因静态骨骼肌收缩而导致的平均动脉压(MAP)和心率(HR)升高方面的作用。
在麻醉大鼠中使用微透析方法,我们将AR - AT2拮抗剂注入延髓头端(RVLM)和尾端(CVLM)VLM,并确定其对肌肉收缩后心血管反应和谷氨酸/γ-氨基丁酸神经传递的影响。向RVLM双侧微透析选择性AT2拮抗剂PD 123319(10微摩尔)30分钟,可增强静态肌肉收缩期间的MAP和HR反应。同时,该药物增加了RVLM内的谷氨酸水平并降低了γ-氨基丁酸水平。停药60分钟后,仅MAP和HR值恢复到基线,而对肌肉收缩的神经递质水平未恢复。相比之下,向CVLM双侧微透析该药物可减弱静态肌肉收缩期间的心血管反应,降低谷氨酸水平并增加γ-氨基丁酸水平。然而,停药60分钟后仅心血管反应恢复。这些结果表明,RVLM和CVLM内的AT2在运动加压反射过程中调节神经传递和心血管功能方面发挥着重要的不同作用。